Free Trial
Tada emoji MarketBeat All Access Sale — Buy Now For Just $5

Merck & Co., Inc. (MRK) Short Interest Ratio & Short Volume

Merck & Co., Inc. logo
$80.73 +0.36 (+0.45%)
Closing price 08/8/2025 03:59 PM Eastern
Extended Trading
$80.79 +0.06 (+0.07%)
As of 04:53 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Merck & Co., Inc. Short Interest Data

Merck & Co., Inc. (MRK) has a short interest of 28.77 million shares, representing 1.15% of the float (the number of shares available for trading by the public). This marks a -18.01% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.9, indicating that it would take 1.9 days of the average trading volume of 12.25 million shares to cover all short positions.

Current Short Interest
28,770,000 shares
Previous Short Interest
35,090,000 shares
Change Vs. Previous Month
-18.01%
Dollar Volume Sold Short
$2.35 billion
Short Interest Ratio
1.9 Days to Cover
Last Record Date
July 15, 2025
Outstanding Shares
2,497,780,000 shares
Short Percent of Float
1.15%
Today's Trading Volume
6,882,063 shares
Average Trading Volume
12,245,771 shares
Today's Volume Vs. Average
56%
Short Selling Merck & Co., Inc.?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Merck & Co., Inc. and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

MRK Short Interest Over Time

MRK Days to Cover Over Time

MRK Percentage of Float Shorted Over Time

Merck & Co., Inc. Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/15/202528,770,000 shares $2.35 billion -18.0%1.2%1.9 $81.54
6/30/202535,090,000 shares $2.78 billion -2.0%1.4%2.1 $79.19
6/15/202535,800,000 shares $2.92 billion +3.6%1.4%2.2 $81.68
5/31/202534,560,000 shares $2.66 billion -16.3%1.4%2.1 $76.86
5/15/202541,270,000 shares $3.08 billion +11.1%1.6%2.5 $74.68
4/30/202537,140,000 shares $3.17 billion -11.4%1.5%2.2 $85.23
4/15/202541,930,000 shares $3.28 billion +10.5%1.7%2.4 $78.28
3/31/202537,940,000 shares $3.40 billion +2.2%1.5%2.3 $89.74
3/15/202537,130,000 shares $3.52 billion -9.3%1.5%2.4 $94.72
2/28/202540,940,000 shares $3.78 billion +27.1%1.6%2.8 $92.23
2/15/202532,210,000 shares $2.67 billion +8.8%1.3%2.3 $83.01
1/31/202529,600,000 shares $2.92 billion -13.3%1.2%2.3 $98.80
1/15/202534,120,000 shares $3.42 billion +10.3%N/A3 $100.20
12/31/202430,930,000 shares $3.08 billion -3.4%N/A2.8 $99.48
12/15/202432,030,000 shares $3.27 billion -2.3%N/A2.8 $102.00
11/30/202432,790,000 shares $3.33 billion +24.6%N/A3.1 $101.64
11/15/202426,320,000 shares $2.53 billion +0.3%N/A2.6 $96.30
10/31/202426,230,000 shares $2.68 billion +0.7%N/A2.8 $102.32
10/15/202426,040,000 shares $2.90 billion -4.5%N/A2.6 $111.54
9/30/202427,260,000 shares $3.10 billion +9.9%N/A2.9 $113.56
9/15/202424,810,000 shares $2.87 billion -4.3%N/A2.5 $115.86
8/31/202425,910,000 shares $3.07 billion +4.4%N/A2.7 $118.45
8/15/202424,810,000 shares $2.81 billion -7.2%N/A2.6 $113.31
7/31/202426,720,000 shares $3.02 billion +8.8%N/A2.9 $113.13
7/15/202424,570,000 shares $3.15 billion +5.2%N/A3 $128.12
6/30/202423,350,000 shares $2.89 billion +19.9%N/A2.8 $123.80
6/15/202419,470,000 shares $2.52 billion -4.6%N/A2.6 $129.48
5/31/202420,410,000 shares $2.56 billion +0.7%N/A2.5 $125.58
5/15/202420,270,000 shares $2.67 billion +8.1%N/A2.5 $131.74
4/30/202418,750,000 shares $2.42 billion -8.2%N/A2.3 $129.19
4/15/202420,430,000 shares $2.58 billion +4.3%N/A2.5 $126.19
3/31/202419,590,000 shares $2.58 billion -15.4%N/A2.3 $131.95
3/15/202423,160,000 shares $2.81 billion +39.5%N/A2.8 $121.53
2/29/202416,600,000 shares $2.11 billion -1.3%N/A2.1 $127.15
2/15/202416,820,000 shares $2.13 billion -1.2%N/A2 $126.54
1/31/202417,020,000 shares $2.06 billion -18.2%N/A2 $120.78
1/15/202420,810,000 shares $2.47 billion +16.5%N/A2.5 $118.63
12/31/202317,870,000 shares $1.95 billion +32.7%N/A2.2 $109.02
12/15/202313,470,000 shares $1.42 billion -19.3%N/A1.7 $105.64
11/30/202316,690,000 shares $1.71 billion -7.4%N/A2.3 $102.48
The End of Elon Musk…? (Ad)

The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.

Click here to see why the "End of Elon" crowd is about to be wrong again.
11/15/202318,020,000 shares $1.83 billion +9.8%N/A2.7 $101.35
10/31/202316,410,000 shares $1.68 billion +3.9%N/A2.5 $102.68
10/15/202315,790,000 shares $1.64 billion +6.5%N/A2.4 $104.01
9/30/202314,830,000 shares $1.53 billion +6.8%N/A2.2 $102.95
9/15/202313,880,000 shares $1.49 billion -5.2%N/A2 $107.47
8/31/202314,640,000 shares $1.60 billion +1.2%N/A2 $108.98
8/15/202314,460,000 shares $1.57 billion +2.3%N/A1.9 $108.66
7/31/202314,140,000 shares $1.51 billion -21.1%N/A1.9 $106.65
7/15/202317,920,000 shares $1.92 billion +6.3%N/A2.5 $107.34
6/30/202316,860,000 shares $1.94 billion +12.7%N/A2.4 $115.36
6/15/202314,960,000 shares $1.64 billion -4.4%N/A2.1 $109.40
5/31/202315,650,000 shares $1.73 billion -20.2%N/A2.1 $110.41
5/15/202319,620,000 shares $2.28 billion +2.7%N/A2.6 $116.37
4/30/202319,100,000 shares $2.21 billion -10.5%N/A2.5 $115.47
4/15/202321,340,000 shares $2.46 billion -3.3%N/A2.6 $115.31
3/31/202322,070,000 shares $2.35 billion +13.0%N/A2.6 $106.39
3/15/202319,540,000 shares $2.10 billion -4.9%N/A2.3 $107.63
2/28/202320,550,000 shares $2.18 billion +5.6%N/A2.4 $106.24
2/15/202319,470,000 shares $2.10 billion +13.5%N/A2.2 $107.68
1/31/202317,150,000 shares $1.84 billion +5.7%N/A1.9 $107.41
1/15/202316,220,000 shares $1.82 billion -5.8%N/A1.7 $112.25
12/30/202217,210,000 shares $1.91 billion -16.1%N/A1.8 $110.95
12/15/202220,510,000 shares $2.25 billion +4.5%N/A2.2 $109.63
11/30/202219,630,000 shares $2.16 billion +0.8%N/A2.1 $110.12
11/15/202219,470,000 shares $1.94 billion -4.4%N/A2.2 $99.60
10/31/202220,360,000 shares $2.06 billion +5.8%N/A2.4 $101.20
10/15/202219,240,000 shares $1.77 billion -5.7%N/A2.3 $92.18
9/30/202220,400,000 shares $1.76 billion +4.9%N/A2.5 $86.12
9/15/202219,450,000 shares $1.69 billion +0.8%N/A2.2 $86.75
8/31/202219,290,000 shares $1.65 billion -2.4%N/A2 $85.36
8/15/202219,760,000 shares $1.79 billion +17.7%N/A1.9 $90.60
7/31/202216,790,000 shares $1.50 billion -17.4%N/A1.5 $89.34
7/15/202220,330,000 shares $1.93 billion -0.7%N/A1.8 $94.96
6/30/202220,470,000 shares $1.87 billion +2.6%N/A1.7 $91.17
6/15/202219,950,000 shares $1.69 billion -14.6%N/A1.7 $84.63
5/31/202223,350,000 shares $2.15 billion +8.3%N/A2 $92.03
5/15/202221,570,000 shares $1.95 billion +27.0%N/A1.9 $90.41
4/30/202216,980,000 shares $1.51 billion -11.9%0.7%1.5 $88.69
4/15/202219,280,000 shares $1.68 billion +14.4%0.8%1.6 $86.91
3/31/202216,860,000 shares $1.38 billion +1.6%0.7%1.4 $82.05
3/15/202216,590,000 shares $1.30 billion -14.8%0.7%1.4 $78.64
2/28/202219,460,000 shares $1.49 billion +10.3%0.8%1.5 $76.58
2/15/202217,650,000 shares $1.37 billion -12.2%0.7%1.3 $77.81
1/31/202220,090,000 shares $1.64 billion -14.5%0.8%1.4 $81.48
1/15/202223,490,000 shares $1.91 billion +1.4%0.9%1.7 $81.38
12/31/202123,160,000 shares $1.77 billion +8.8%0.9%1.7 $76.64
12/15/202121,290,000 shares $1.60 billion +13.7%0.8%1.3 $75.29
11/30/202118,730,000 shares $1.40 billion -15.6%0.7%1.1 $74.91
11/15/202122,180,000 shares $1.86 billion +6.4%0.9%1.5 $83.69
10/29/202120,840,000 shares $1.83 billion -4.8%N/A1.4 $88.05
The End of Elon Musk…? (Ad)

The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.

Click here to see why the "End of Elon" crowd is about to be wrong again.
10/15/202121,880,000 shares $1.71 billion -3.0%N/A1.6 $78.33
9/30/202122,560,000 shares $1.69 billion -19.9%N/A1.7 $75.11
9/15/202128,180,000 shares $2.05 billion +2.8%N/A2.7 $72.81
8/31/202127,420,000 shares $2.09 billion +2.7%N/A2.7 $76.29
8/13/202126,690,000 shares $2.05 billion +15.2%N/A2.5 $76.72
7/30/202123,170,000 shares $1.78 billion +4.1%N/A2.1 $76.87
7/15/202122,250,000 shares $1.73 billion -7.0%N/A1.9 $77.90
6/30/202123,930,000 shares $1.86 billion +8.4%N/A2 $77.77
6/15/202122,070,000 shares $1.67 billion +17.2%N/A1.9 $75.70
5/28/202118,830,000 shares $1.43 billion -9.4%N/A1.5 $75.89
5/14/202120,790,000 shares $1.64 billion +1.6%0.8%1.7 $78.69
4/30/202120,470,000 shares $1.51 billion -2.6%0.8%1.6 $73.68
4/15/202121,020,000 shares $1.61 billion -11.5%0.8%1.8 $76.40
3/31/202123,740,000 shares $1.83 billion +30.9%0.9%2 $76.96
3/15/202118,140,000 shares $1.35 billion -11.0%0.7%1.5 $74.60
2/26/202120,380,000 shares $1.52 billion +10.3%0.8%2 $74.62
2/12/202118,470,000 shares $1.38 billion -0.6%0.7%1.9 $74.74
1/29/202118,580,000 shares $1.45 billion +1.9%0.7%2 $77.92
1/15/202118,230,000 shares $1.50 billion +14.2%0.7%2 $82.17
12/31/202015,970,000 shares $1.29 billion +17.5%0.6%1.8 $80.59
12/15/202013,590,000 shares $1.09 billion +0.7%0.5%1.6 $80.32
11/30/202013,500,000 shares $1.08 billion +0.3%N/A1.6 $79.86
11/15/202013,460,000 shares $1.09 billion -8.8%0.5%1.6 $81.09
10/30/202014,750,000 shares $1.12 billion +40.1%0.6%1.8 $75.89
10/15/202010,530,000 shares $847.77 million -4.1%0.4%1.3 $80.51
9/30/202010,980,000 shares $910.79 million +0.1%0.4%1.4 $82.95
9/15/202010,970,000 shares $923.78 million -9.4%0.4%1.4 $84.21
8/31/202012,110,000 shares $1.03 billion +2.6%0.5%1.4 $85.27
8/14/202011,800,000 shares $985.06 million -13.9%0.5%1.3 $83.48

MRK Short Interest - Frequently Asked Questions

What is Merck & Co., Inc.'s current short interest?

Short interest is the volume of Merck & Co., Inc. shares that have been sold short but have not yet been closed out or covered. As of July 15th, investors have sold 28,770,000 shares of MRK short. 1.15% of Merck & Co., Inc.'s shares are currently sold short. Learn More on Merck & Co., Inc.'s current short interest.

What is a good short interest ratio for Merck & Co., Inc.?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MRK shares currently have a short interest ratio of 2.0. Learn More on Merck & Co., Inc.'s short interest ratio.

Which institutional investors are shorting Merck & Co., Inc.?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Merck & Co., Inc.: Garda Capital Partners LP, Mirae Asset Securities USA Inc., Simplex Trading LLC, Bank of Montreal Can, Wolverine Asset Management LLC, Insight Advisors LLC PA, Allianz Asset Management GmbH, Twin Tree Management LP, Concurrent Investment Advisors LLC, Total Wealth Planning & Management Inc., IMC Chicago LLC, Quaker Wealth Management LLC, Jane Street Group LLC, CTC LLC, Goldman Sachs Group Inc., Parallax Volatility Advisers L.P., Millennium Management LLC, Cubist Systematic Strategies LLC, Caption Management LLC, MAI Capital Management, Twin Tree Management LP, Susquehanna International Group LLP, BNP Paribas Financial Markets, Eisler Capital Management Ltd., PEAK6 LLC, Jane Street Group LLC, Walleye Trading LLC, Walleye Capital LLC, Capital Fund Management S.A., Garda Capital Partners LP, Credit Agricole S A, Maven Securities LTD, Marathon Trading Investment Management LLC, Persistent Asset Partners Ltd, Arrowpoint Investment Partners Singapore Pte. Ltd., Simplex Trading LLC, JPMorgan Chase & Co., Wolverine Asset Management LLC, Citigroup Inc., and XY Capital Ltd. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Merck & Co., Inc.?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.15% of Merck & Co., Inc.'s floating shares are currently sold short.

Is Merck & Co., Inc.'s short interest increasing or decreasing?

Merck & Co., Inc. saw a decline in short interest in the month of July. As of July 15th, there was short interest totaling 28,770,000 shares, a decline of 18.0% from the previous total of 35,090,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Merck & Co., Inc.'s short interest compare to its competitors?

1.15% of Merck & Co., Inc.'s shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Merck & Co., Inc.: Amgen Inc. (2.74%), Corcept Therapeutics Incorporated (11.96%), Gilead Sciences, Inc. (1.82%), Moderna, Inc. (19.34%), Vertex Pharmaceuticals Incorporated (1.64%), AbbVie Inc. (0.89%), Bristol Myers Squibb Company (1.89%), Johnson & Johnson (0.76%), Eli Lilly and Company (0.90%), Pfizer Inc. (1.75%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks.

What does it mean to sell short Merck & Co., Inc. stock?

Short selling MRK is an investing strategy that aims to generate trading profit from Merck & Co., Inc. as its price is falling. MRK shares are trading up $0.36 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Merck & Co., Inc.?

A short squeeze for Merck & Co., Inc. occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MRK, which in turn drives the price of the stock up even further.

How often is Merck & Co., Inc.'s short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MRK, twice per month. The most recent reporting period available is July, 15 2025.



Related Companies
Short Interest Tools

This page (NYSE:MRK) was last updated on 8/11/2025 by MarketBeat.com Staff
From Our Partners
Your blueprint for crypto wealth
Mark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…
Crypto 101 Media | Sponsored
Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...
Porter & Company | Sponsored
HIDDEN IN THE BOOK OF GENESIS…
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...
Paradigm Press | Sponsored
Trump set to Boost Social Security Checks by 400%?
If you're collecting or planning to collect social security... You should see this presentation about Presi...
InvestorPlace | Sponsored
REVEALED FREE: Our top 3 stocks to own in 2025 and beyond
Every time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...
Weiss Ratings | Sponsored
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsored
GENIUS Act: Cancel Your Money?
A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...
Priority Gold | Sponsored
Man Who Called Nvidia at $1.10 Says Buy This Now...
In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...
The Oxford Club | Sponsored